

Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.


Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.
Discover Tomorrow’s Winning Stocks! Thank you for subscribing. Something went wrong. Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox. […]
[embedyt] https://www.youtube.com/watch?v=ZL8tb5EFlWQ[/embedyt] Medicine Man Technologies (OTC: MDCL) CEO Interview with Andy Williams, co-founder, and CEO. In this update to our December 2018 interview, Andy provides an update on the company’s progress into a vertically integrated […]
Today MedPharm Holdings announced the successful formulation and development of micro-emulsified, cannabis infused, dissolvable thin strips “Melts,” powered with their proprietary Lipophilic Enhanced Absorption Formulation (LEAF) technology. The oral strip is unique in that it […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
